ClinConnect ClinConnect Logo
Search / Trial NCT04198259

Interventional Devascularization Plus HVPG-Guided Carvedilol Therapy vs TIPS

Launched by AIR FORCE MILITARY MEDICAL UNIVERSITY, CHINA · Dec 11, 2019

Trial Information

Current as of June 05, 2025

Unknown status

Keywords

Tips Hvpg Brto Nsbb

ClinConnect Summary

Gastric varices (GV) are present in around 20% of patients with cirrhosis. Bleeding from GV accounts for 10-20% of all variceal bleeding. GV are classified according to their location in the stomach and their relationship with esophageal varices (EV). Accordingly, GV are divided into gastroesophageal varices (GOV) and isolated gastric varices (IGV) . The management of type 1 GOV, which extend from the esophagus along the lesser curvature of the stomach, is similar to the management of EV. Historically, bleeding from type 2 GOV (i.e. GOV extending into the fundus), type 1 IGV (i.e. located i...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Liver cirrhosis diagnosed by clinical examination, imaging or biopsy
  • Patients with a previous history of variceal hemorrhage
  • Gastric variceal confirmed by an endoscopic examination, including IGV1 or IGV2
  • Aged 18 to 75 years
  • Adequate liver and kidney function, including Child-Turcotte-Pugh score \< 12, MELD score \<19, and serum creatinine less than 2 times the upper limit of normal.
  • Exclusion Criteria:
  • Active variceal bleeding
  • Esophageal variceal, including GOV1 or GOV2 type, mainly esophageal varices;
  • Refractory ascites
  • Patients with contraindication to treatment of TIPS, including congestive heart failure, NYHA III and IV, pulmonary arterial hypertension(\>50mmHg), polycystic liver, intrahepatic duct dilatation, spontaneous bacterial peritonitis, hepatic encephalopathy
  • Patients with contraindication to treatment of Carvedilol, including asthma, insulin-dependent diabetes, peripheral vascular diseases
  • Child-Turcotte-Pugh score \>=12, or MELD score \>=19
  • Budd-Chiari syndrome
  • The main portal vein thrombosis is greater than 50%
  • Malignancies
  • An uncontrolled infection
  • Previously treated with TIPS, splenectomy pericardia vascular disconnection, or surgical shunts
  • HIV or HIV related illness
  • Allergic to contrast agent
  • Lactating or pregnant
  • Non-compliant patients

About Air Force Military Medical University, China

The Air Force Military Medical University (AFMMU) in China is a prestigious institution dedicated to advancing military medicine and healthcare research. With a strong emphasis on clinical trials and innovative medical practices, AFMMU integrates cutting-edge scientific research with practical applications to enhance the health and well-being of military personnel and the broader community. The university fosters collaboration among various disciplines, promoting a robust environment for training healthcare professionals and conducting impactful studies that address critical health challenges. Through its commitment to excellence and rigorous scientific methodology, AFMMU plays a pivotal role in shaping the future of military and civilian healthcare.

Locations

Patients applied

0 patients applied

Trial Officials

Jun Tie, M.D.,Ph.D.

Principal Investigator

Air Force Military Medical University, China

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials